https://abcamchem.com/mid-term....-functionality-as-we
Multi-target drugs may interdict the progress of advertising through a synergistic process. A neuromodulator, 2-((1H-benzo[d]imidazole-2-yl)methoxy)benzoic acid (BIBA), comprising an Aβ-targeting group and a derivative of anti-inflammatory aspirin ended up being designed as a possible anti-AD agent. BIBA shows an extraordinary inhibitory influence on the self- and metal-induced Aβ aggregations and shows outstanding anti-inflammatory task simultaneously. The neurotoxicity o
Like
Comment
Share
